United States v. Holder

135 F.4th 887
CourtCourt of Appeals for the Tenth Circuit
DecidedApril 22, 2025
Docket23-1021
StatusPublished

This text of 135 F.4th 887 (United States v. Holder) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Holder, 135 F.4th 887 (10th Cir. 2025).

Opinion

Appellate Case: 23-1021 Document: 117 Date Filed: 04/22/2025 Page: 1 FILED United States Court of Appeals PUBLISH Tenth Circuit

UNITED STATES COURT OF APPEALS April 22, 2025

Christopher M. Wolpert FOR THE TENTH CIRCUIT Clerk of Court _________________________________

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

v. No. 23-1021

BRUCE HOLDER,

Defendant - Appellant. _________________________________

Appeal from the United States District Court for the District of Colorado (D.C. No. 1:18-CR-381-CMA-GPG-1) _________________________________

Ann Marie Taliaferro, Brown Bradshaw & Moffat, Salt Lake City, Utah (Benjamin Miller, Salt Lake City, Utah, with her on the briefs) for Defendant-Appellant.

Kyle Brenton, Assistant United States Attorney (Matthew T. Kirsch, Acting United States Attorney, with him on the brief) United States Attorney’s Office, Denver, Colorado, for Plaintiff-Appellee. _________________________________

Before TYMKOVICH, BALDOCK, and EID, Circuit Judges. _________________________________

TYMKOVICH, Circuit Judge. _________________________________

Bruce Holder ran a fentanyl distribution ring that distributed thousands of pills

in western Colorado. He was tried and convicted of four federal drug crimes,

including two predicated on the death and serious injury of buyers of his product. Appellate Case: 23-1021 Document: 117 Date Filed: 04/22/2025 Page: 2

Holder alleges that his trial was unconstitutional because the district court’s

COVID-19 protocols violated his public trial right. He also contends Colorado’s jury

pool unreasonably underrepresents members of certain racial groups. Finally, he

argues that several counts were constructively amended at trial, and the evidence

could not support the jury’s finding that his fentanyl distribution resulted in a

victim’s death.

We AFFIRM. The district court’s restrictions were no more restrictive than

necessary to protect public health against the perceived harms from COVID-19. Nor

did an unreasonable racial disparity exist in the members of the jury pool. The

indictment was not constructively amended as no essential elements were altered.

Finally, the jury reasonably found that Holder’s fentanyl distribution resulted in a

I. Background

A. The Underlying Facts

1. The Conspiracy

Holder was accused of managing a network of friends and family to distribute

fentanyl. He would instruct his friends and family to drive from Grand Junction,

Colorado to Sonora, Mexico. While they vacationed in Puerto Peñasco, their cars

would be stocked with fentanyl. Each time, more than 2,000 pills would be stashed

in hidden compartments in the cars. By the summer of 2017, Holder’s wife, Marie

Matos, was making the trip to Mexico every two weeks, bringing back more than

50,000 pills. 2 Appellate Case: 23-1021 Document: 117 Date Filed: 04/22/2025 Page: 3

The pills they brought back were counterfeits that looked like regular

oxycodone. They were small, circular, blue, and were stamped with a capital M

inside a box on one side and the number thirty on the other. They were made to

appear exactly like oxycodone manufactured by Mallinckrodt Pharmaceuticals—the

“box M” is Mallinckrodt’s trademark. Holder knew that these were counterfeit pills

that contained fentanyl.

Holder’s friends and family would distribute the pills. Holder’s circle

included his wife, son, daughter, stepdaughter, and several close friends. All of

whom testified that Holder was the ringleader of the conspiracy controlling the

supply and prices.

2. The Overdoses

Zack Green both used and sold Holder’s pills. Green bought pills either from

Holder directly or through Holder’s distributor, Christopher Huggett. Holder and

Huggett were Green’s only source of pills, and Green knew of no other source for

blue fentanyl pills in the area.

Green often sold the pills he bought to his coworker, Jon Ellington. On

December 26, 2017, Ellington gave Green cash for ten pills. Green then bought

twelve pills from Huggett who bought them from Holder. He kept two for himself

and delivered the rest to Ellington. Two days later, Green smoked one of those blue

pills in his car at work. He took two hits, put the car in drive, and passed out. The

assistant manager found Green unconscious when his vehicle hit the building. She

3 Appellate Case: 23-1021 Document: 117 Date Filed: 04/22/2025 Page: 4

pulled Green from the car and called 911. The paramedics administered Narcan and

took Green to the hospital. Green was discharged a few hours later.

On the same day as Green’s episode, Ellington’s housemate found him

overdosed in his room. Ellington had not shown up for work for two days, and, after

receiving a call from Ellington’s employer, his housemate found him slumped over in

a chair in his room. Paramedics administered Narcan but could not revive him.

Ellington had a syringe in his lap and a tourniquet on the floor between his

legs. On his dresser, his housemates found a spoon and cotton ball with blue residue

on them. They also found several pill bottles in that dresser. One bottle contained a

pill that was the same color blue as the residue. The rough markings the housemates

described were later identified as the “box M” consistent with Holder’s fentanyl pills.

Other substances were also found in Ellington’s room. Law enforcement found one

irregular pill identified as MDMA, a stimulant and psychedelic drug also known as

ecstasy, and a tan substance identified as DMT, a powerful psychedelic drug.

The toxicology reports pointed to fentanyl as the cause of death. Ellington’s

blood tests found a fentanyl concentration of 18 nanograms per milliliter—between

six and nine times higher than expected from a typical prescription fentanyl patch.

Two coroners concluded that this concentration was the but-for cause of Ellington’s

death. Although the defense’s expert forensic pathologist recognized fentanyl

intoxication as “a correct cause of death,” she refused to conclude it with certainty

because testing was limited. R., Vol. VIII at 1273. She pointed out that the basic

toxicology test did not examine Ellington’s urine and did not test for DMT even

4 Appellate Case: 23-1021 Document: 117 Date Filed: 04/22/2025 Page: 5

though the substance was found in his room. The only substance other than fentanyl

the basic test detected was THC.

B. Holder’s Prosecution

1. The Indictment

The second superseding indictment charged six defendants with a total of

sixteen counts. Holder went to trial on four counts: (1) conspiracy to distribute 400

grams or more of counterfeit fentanyl, (2) distribution of fentanyl resulting in the

death of Ellington, (3) distribution of fentanyl resulting in serious bodily injury to

Green, and (4) distribution of a counterfeit controlled substance. See 21 U.S.C.

§ 841(a)–(b).

2. The Jury Venire

The District of Colorado’s Jury Plan provides that the Master Jury Wheel will

come from a source list made up of the Colorado General Election Voter Registration

List supplemented by the list of licensed drivers and state-issued adult identification

cards. From this “master wheel” jurors are randomly selected for a given grand or

petit jury.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Presley v. Georgia
558 U.S. 209 (Supreme Court, 2010)
Duren v. Missouri
439 U.S. 357 (Supreme Court, 1979)
Gannett Co. v. DePasquale
443 U.S. 368 (Supreme Court, 1979)
Waller v. Georgia
467 U.S. 39 (Supreme Court, 1984)
Gall v. United States
552 U.S. 38 (Supreme Court, 2007)
United States v. Chanthadara
230 F.3d 1237 (Tenth Circuit, 2000)
United States v. Brown
400 F.3d 1242 (Tenth Circuit, 2005)
United States v. Orange
447 F.3d 792 (Tenth Circuit, 2006)
United States v. Bishop
469 F.3d 896 (Tenth Circuit, 2006)
Richison v. Ernest Group, Inc.
634 F.3d 1123 (Tenth Circuit, 2011)
United States v. Flood
635 F.3d 1255 (Tenth Circuit, 2011)
The United States of America v. Terry Yazzie
660 F.2d 422 (Tenth Circuit, 1982)
United States v. Alfred Lee Apodaca
843 F.2d 421 (Tenth Circuit, 1988)
Gilbert Nieto v. George Sullivan
879 F.2d 743 (Tenth Circuit, 1989)
United States v. George Don Galloway
56 F.3d 1239 (Tenth Circuit, 1995)
United States v. Anthony Gault
141 F.3d 1399 (Tenth Circuit, 1998)
United States v. Michael D. Shinault
147 F.3d 1266 (Tenth Circuit, 1998)
United States v. DeChristopher
695 F.3d 1082 (Tenth Circuit, 2012)
United States v. Addison
708 F.3d 1181 (Tenth Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
135 F.4th 887, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-holder-ca10-2025.